Fingolimod Hydrochloride is primarily used in the treatment of multiple sclerosis (MS). It works by modulating the immune system to reduce the frequency of relapses and slow the progression of the disease. The drug achieves this by trapping certain immune cells in the lymph nodes, preventing them from reaching the central nervous system and causing inflammation. It is often prescribed for patients with relapsing-remitting MS to improve their quality of life and reduce the severity of symptoms. Additionally, Fingolimod Hydrochloride is sometimes used in clinical trials to explore its potential benefits in other autoimmune conditions. Patients taking this medication require regular monitoring due to its effects on the immune system and potential side effects.